Efficacy and safety of mesenchymal stromal cells in preclinical models of acute lung injury: A systematic review protocol

Systematic Reviews

Volumn 3, Issue 1, 2014, Pages

  Lalu, Manoj M ^a,b   Moher, David ^a,b   Marshall, John ^c   Fergusson, Dean ^b   Mei, Shirley H J ^b   Macleod, Malcolm ^d   Griffin, Gilly ^e   Turgeon, Alexis F ^f   Rudnicki, Michael ^b   Fishman, Jason ^a   Avey, Marc T ^b   Skidmore, Becky ^g   Grimshaw, Jeremy M ^a,b   Stewart, Duncan J ^a,b   Singh, Kavita ^b   McIntyre, Lauralyn ^a,b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e Canadian Council on Animal Care   (Canada)

^f UNIVERSITÉ LAVAL   (Canada)

^g Independent Consultant   (Canada)

Author keywords

Acute lung injury; Acute respiratory distress syndrome; Mesenchymal stem cells; Mesenchymal stromal cells; Preclinical; Systematic review protocol

Indexed keywords

CHEMOKINE RECEPTOR CXCR2; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MYELOPEROXIDASE; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; BRONCHOALVEOLAR LAVAGE FLUID; DEATH; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; HISTOLOGY; HUMAN; HYPOXEMIA; INFLAMMATION; LUNG ALVEOLUS CELL; LUNG ALVEOLUS OXYGEN TENSION; LUNG FUNCTION; MESENCHYMAL STROMA CELL; MORTALITY; NONHUMAN; PATHOGEN CLEARANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SHOCK; SYSTEMATIC REVIEW; TREATMENT OUTCOME; ANIMAL; DISEASE MODEL; MESENCHYMAL STEM CELL TRANSPLANTATION; PHYSIOLOGY; REVIEW;

ACUTE LUNG INJURY; ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; TREATMENT OUTCOME;

EID: 84907262288     PISSN: None     EISSN: 20464053     Source Type: Journal    
DOI: 10.1186/2046-4053-3-48     Document Type: Article

References (51)

1. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, LeGall JR, Morris A, Spragg R: The American-European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J RespirCrit Care Med 1994, 149:818-824.
2. Definition Task Force ARDS, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS: Acute respiratory distress syndrome: the Berlin definition. JAMA 2012, 307:2526-2533.
3. Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, NeffM, Stern EJ, Hudson LD: Incidence and outcomes of acute lung injury. N Engl J Med 2005, 353:1685-1693.
4. Phua J, Badia JR, Adhikari NK, Friedrich JO, Fowler RA, Singh JM, Scales DC, Stather DR, Li A, Jones A, Gattas DJ, Hallett D, Tomlinson G, Stewart TE, Ferguson ND: Has mortality from acute respiratory distress syndrome decreased over time? A systematic review. Am J RespirCrit Care Med 2009, 179:220-227.
5. Herridge MS, Cheung AM, Tansey CM, Matte-Martyn A, Diaz-Granados N, Al Saidi F, Cooper AB, Guest CB, Mazer CD, Mehta S, Stewart TE, Barr A, Cook D, Slutsky AS, Canadian Critical Care Trials Group: One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 2003, 348:683-693.
6. Herridge MS, Tansey CM, Matte A, Tomlinson G, Diaz-Granados N, Cooper A, Guest CB, Mazer CD, Mehta S, Stewart TE, Kudlow P, Cook D, Slutsky AS, Cheung AM, Canadian Critical Care Trials Group: Functional disability 5 years after acute respiratory distress syndrome. N Engl JMed 2011, 364:1293-1304.
7. Canadian Institute for Health Information (CIHI): The Cost of Acute Care Hospital Stays by Medical Condition in Canada, 2004-2005. Ottawa, ON: CIHI; 2008.
8. Bhatia M, Moochhala S: Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J Pathol 2004, 202:145-156.
9. Hayes M, Curley G, Ansari B, Laffey JG: Clinical review: stem cell therapies for acute lung injury/acute respiratory distress syndrome-hope or hype? Crit Care 2012, 16:205.
10. Matthay MA, Ware LB, Zimmerman GA: The acute respiratory distress syndrome. J Clin Invest 2012, 122:2731-2740.
11. Goodman RB, Pugin J, Lee JS, Matthay MA: Cytokine-mediated inflammation in acute lung injury. Cytokine Growth Factor Rev 2003, 14:523-535.
12. O'Grady NP, Preas HL, Pugin J, Fiuza C, Tropea M, Reda D, Banks SM, Suffredini AF: Local inflammatory responses following bronchial endotoxin instillation in humans. Am J RespirCrit Care Med 2001, 163:1591-1598.
13. Gotts JE, Matthay MA: Mesenchymal stem cells and acute lung injury. Crit Care Clin 2011, 27:719-733.
14. National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, De Boisblanc B, Connors AF Jr, Hite RD, Harabin AL: Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 2006, 354:2564-2575.
15. Papazian L, Forel JM, Gacouin A, Penot-Ragon C, Perrin G, Loundou A, Jaber S, Arnal JM, Perez D, Seghboyan JM, Constantin JM, Courant P, Lefrant JY, Guerin C, Prat G, Morange S, Roch A, ACURASYS Study Investigators: Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 2010, 363:1107-1116.
16. Guerin C, Reignier J, Richard JC, Beuret P, Gacouin A, Boulain T, Mercier E, Badet M, Mercat A, Baudin O, Clavel M, Chatellier D, Jaber S, Rosselli S, Mancebo J, Sirodot M, Hilbert G, Bengler C, Richecoeur J, Gainnier M, Bayle F, Bourdin G, Leray V, Girard R, Baboi L, Ayzac L, PROSEVA Study Group: Prone positioning in severe acute respiratory distress syndrome. N Engl J Med 2013, 368:2159-2168.
17. da Silva ML, Chagastelles PC, Nardi NB: Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 2006, 119:2204-2213.
18. Crisan M, Yap S, Casteilla L, Chen CW, Corselli M, Park TS, Andriolo G, Sun B, Zheng B, Zhang L, Norotte C, Teng PN, Traas J, Schugar R, Deasy BM, Badylak S, Buhring HJ, Giacobino JP, Lazzari L, Huard J, Peault B: A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008, 3:301-313.
19. Crisostomo PR, Wang M, Markel TA, Lahm T, Abarbanell AM, Herrmann JL, Meldrum DR: Stem cell mechanisms and paracrine effects: potential in cardiac surgery. Shock 2007, 28:375-383.
20. Islam MN, Sun L, Lindert J, Das SR, Bhattacharya J: Restoration of alveolar bioenergetics by bone marrow-derived mesenchymal stromal cells [abstract]. Am J RespirCrit Care Med 2011, doi:10.1164/ajrccm-conference.2011.183.1_Meeting Abstracts. A1245.
21. Wang L, Tu XH, Zhao P, Song JX, Zou ZD: Protective effect of transplanted bone marrow-derived mesenchymal stem cells on pancreatitisassociated lung injury in rats. Mol Med Rep 2012, 6:287-292.
22. Tai WL, Dong ZX, Zhang DD, Wang DH: Therapeutic effect of intravenous bone marrow-derived mesenchymal stem cell transplantation on earlystage LPS-induced acute lung injury in mice. Nan Fang Yi Ke Da XueXue Bao 2012, 32:283-290.
23. Danchuk S, Ylostalo JH, Hossain F, Sorge R, Ramsey A, Bonvillain RW, Lasky JA, Bunnell BA, Welsh DA, Prockop DJ, Sullivan DE: Human multipotent stromal cells attenuate lipopolysaccharide-induced acute lung injury in mice via secretion of tumor necrosis factor-alpha-induced protein 6. Stem Cell Res Ther 2011, 2:27.
24. Kim ES, Chang YS, Choi SJ, Kim JK, Yoo HS, Ahn SY, Sung DK, Kim SY, Park YR, Park WS: Intratracheal transplantation of human umbilical cord blood-derived mesenchymal stem cells attenuates Escherichia coliinduced acute lung injury in mice. Respir Res 2011, 12:108.
25. Yang H, Wen Y, Bin J, Hou-You Y, Yu-Tong W: Protection of bone marrow mesenchymal stem cells from acute lung injury induced by paraquat poisoning. ClinToxicol (Phila) 2011, 49:298-302.
26. Manning E, Pham S, Li S, Vazquez-Padron RI, Mathew J, Ruiz P, Salgar SK: Interleukin-10 delivery via mesenchymal stem cells: a novel gene therapy approach to prevent lung ischemia-reperfusion injury. Hum Gene Ther 2010, 21:713-727.
27. Krasnodembskaya A, Song Y, Fang X, Gupta N, Serikov V, Lee JW, Matthay MA: Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37. Stem Cells 2010, 28:2229-2238.
28. Mei SH, McCarter SD, Deng Y, Parker CH, Liles WC, Stewart DJ: Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1. PLoS Med 2007, 4:e269.
29. Gupta N, Su X, Popov B, Lee JW, Serikov V, Matthay MA: Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J Immunol 2007, 179:1855-1863.
30. Matute-Bello G, Downey G, Moore BB, Groshong SD, Matthay MA, Slutsky AS, Kuebler WM, Acute Lung Injury in Animals Study Group: An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals. Am J Respir Cell MolBiol 2011, 44:725-738.
31. Dominici M, Le BK, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E: Minimal criteria for defining multipotent mesenchymal stromal cells: the International Society for Cellular Therapy position statement. Cytotherapy 2006, 8:315-317.
32. Mei SH, Haitsma JJ, Dos Santos CC, Deng Y, Lai PF, Slutsky AS, Liles WC, Stewart DJ: Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis. Am J RespirCrit Care Med 2010, 182:1047-1057.
33. Nemeth K, Leelahavanichkul A, Yuen PS, Mayer B, Parmelee A, Doi K, Robey PG, Leelahavanichkul K, Koller BH, Brown JM, Hu X, Jelinek I, Star RA, Mezey E: Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 2009, 15:42-49.
34. Gonzalez-Rey E, Anderson P, Gonzalez MA, Rico L, Buscher D, Delgado M: Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis. Gut 2009, 58:929-939.
35. McGowan J, Sampson M, Lefebvre C: An evidence based checklist for the peer review of electronic search strategies (PRESS EBC). Evid Based Lib Inform Prac 2010, 5(1):149-154.
36. de Vries RB, Hooijmans CR, Tillema A, Leenaars M, Ritskes-Hoitinga M: A search filter for increasing the retrieval of animal studies in Embase. Lab Anim 2011, 45:268-270.
37. Hooijmans CR, Tillema A, Leenaars M, Ritskes-Hoitinga M: Enhancing search efficiency by means of a search filter for finding all studies on animal experimentation in PubMed. Lab Anim 2010, 44:170-175.
38. Moher D, Liberati A, TetzlaffJ, Altman DG: Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009, 151:264-269.
39. Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA, Cochrane Bias Methods Group; Cochrane Statistical Methods Group: The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. Br Med J 2011, 343:d5928.
40. Henderson VC, Kimmelman J, Fergusson D, Grimshaw JM, Hackam DG: Threats to validity in the design and conduct of preclinical efficacy studies: a systematic review of guidelines for in vivo animal experiments. PLoS Med 2013, 10:e1001489.
41. Kimmelman J, London AJ: Predicting harms and benefits in translational trials: ethics, evidence, and uncertainty. PLoS Med 2011, 8:e1001010.
42. Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG: Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. Osteoarthritis Cartilage 2012, 20:256-260.
43. DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188.
44. Friedrich JO, Adhikari NK, Beyene J: The ratio of means method as an alternative to mean differences for analyzing continuous outcome variables in meta-analysis: a simulation study. BMC Med Res Methodol 2008, 8:32.
45. Higgins JP, Thompson SG: Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21:1539-1558.
46. Hayashino Y, Noguchi Y, Fukui T: Systematic evaluation and comparison of statistical tests for publication bias. J Epidemiol 2005, 15:235-243.
47. Flurkey K, Currer JM, Harrison DE: Mouse models in aging research. In The Mouse in Biomedical Research: Immunology. Volume IV Immunology. 2nd edition. Edited by Fox JG, Barthold S, Davisson M, Newcomer CE, Quimby FW, Smith A. Burlington, MA: Academic; 2007:637-672.
48. Lalu MM, McIntrye L, Pugliese C, Stewart DJ: Safety of cell therapy with mesenchymal stromal cells (MSCs): a systematic review. Am J RespirCrit Care Med 2010, 181:A6043.
49. Hackam DG, Redelmeier DA: Translation of research evidence from animals to humans. JAMA 2006, 296:1731-1732.
50. van der Worp HB, Howells DW, Sena ES, Porritt MJ, Rewell S, O'Collins V, MacLeod RM: Can animal models of disease reliably inform human studies? PLoS Med 2010, 7:e1000245.
51. Sena ES, van der Worp HB, Bath PM, Howells DW, Macleod MR: Publication bias in reports of animal stroke studies leads to major overstatement of efficacy. PLoS Biol 2010, 8:e1000344.